Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?
ConclusionIL-37 inhibition offers the opportunity to immunologically modulate MCs, by suppressing their production of IL-1 family members and reducing the risk of allograft rejection, resulting as a potential good therapeutic new cytokine. Here, we report the relationship between inflammatory MCs, allograft rejection and pro-inflammatory and anti-inflammatory IL-37.
Source: Inflammation Research - Category: Research Source Type: research
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Asthma | Bone Graft | Cancer | Cancer & Oncology | Research | Study | Transplants